ST 2825 - CAS# 894787-30-5 Size:Solid 10 mg it was shown and used

it was shown and used to enhance the survival and cloning efficiency of many primary cell types after single cell dissociation without affecting their self-renewal properties

a type II topoisomerase

Molecular Weight: 158

Formulations containing lodoxamide have been used in the treatment of vernal conjunctivitis and keratitis

and 33 nM in H1975 (EGFRL858R/T790M)

ST 2825 - CAS# 894787-30-5 Size:Solid 10 mg it was shown and usedST 2825 is MyD88 inhibitor. ST2825 provides neuroprotection after experimental traumatic brain injury in mice. ST2825 significantly inhibited the proliferation of and promoted the apoptosis of HCC cells. Moreover, ST2825 significantly decreased bcl 2 expression, increased cleaved caspase 3 expression (P < 0. 05), and reduced p65 nuclear expression (P < 0. 05) in a dose dependent manner. ST2825 inhibits the proliferation of and promotes the apoptosis